Weed Giants Tilray And Curaleaf Ramp Up Presence In Europe, Here’s Why

The European cannabis market is one of the most rapidly expanding markets globally. Prohibition Partners revealed in its latest report on cannabis in Europe that the combined market size of all CBD categories surpassed €2 billion ($2.2 billion) in 2023.

The report called Germany, Czech Republic, Switzerland and the Netherlands “early adopters” that are working on developing regulatory models for the recreational cannabis market, and are “likely to set a precedent for other countries to follow.”

Germany’s recent partial legalization of cannabis has shaken up the industry and moved marijuana stocks, leaving everyone wondering about a domino effect on other European countries.

By the way, the burgeoning European market will be one of many hot topics at Benzinga’s spring cannabis event next month. The Benzinga Cannabis Capital Conference is returning to Florida, in a new venue in Hollywood, on April 16 and 17, 2024.

And, North American cannabis operators are seizing the new opportunity.

See also: Cannabis In Europe Is Smelling Good: No Great Upheavals Or Unexpected Shifts, Says Report

Curaleaf Debuts In The Czech Republic

On Thursday, Curaleaf International, part of Curaleaf Holdings Inc. (OTC:CURLF) – which has already established its presence in the European market – announced its expansion in the Czech Republic, via a new supply agreement with Astrasana Pharma s.r.o.

The collaboration will make Curaleaf International’s EU-GMP flower …

Full story available on Benzinga.com